Acrivon Therapeutics (ACRV) Earnings Date & Reports

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACRV is expected to report earnings to rise 30.61% to -63 cents per share on August 19

Acrivon Therapeutics ACRV Stock Earnings Reports

Q2'26

Est.

$-0.64

Q1'26

Beat

by $0.13

Q4'25

Beat

by $0.72

Q3'25

Beat

by $0.69

Q2'25

Beat

by $0.54

The last earnings report on May 13 showed earnings per share of -49 cents, beating the estimate of -62 cents. With 230.78K shares outstanding, the current market capitalization sits at 68.27M.

View a ticker or compare two or three

Compare

ACRV

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ACRV